Low-dose semaglutide seems to reduce craving and certain drinking outcomes in alcohol use disorder (AUD), according to ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can expire. If ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.

The semaglutide dose was 0.25 mg per week for four weeks, 0.5 mg per week for four weeks, and 1.0 mg for one week, all given during clinic visits. Afterwards, everyone returned to the drinking lab to ...

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout newsletter.

Hims & Hers faces new headwinds in its weight management segment with the Food and Drug Administration ending the shortage of ...

Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...

Ozempic is available on the NHS as a type 2 diabetes treatment with a starting dose of 0.25mg semaglutide once weekly, increasing to 0.5mg after four weeks. Wegovy is offered for weight management and ...